Clinical Trial Update: Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gefitinib for metastatic breast cancer that progressed after antiestrogen therapy and nonsteroidal aromatase inhibitors. The study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED